Table 2 Clinicopathologic characteristics of 100 cases enrolled for validation
Clinicopathologic characteristics | n | |
|---|---|---|
Survival | Survival | 76 |
Death | 24 | |
Gender | Female | 43 |
Male | 57 | |
Histology | Tumor | 54 |
Carcinoma | 46 | |
Myasthenia gravis | No | 69 |
Yes | 31 | |
WHO histological types | A/AB/B1/B2/B3 | 54 |
C | 46 | |
Masaoka stage | I–II | 37 |
III–IV | 63 | |
Radiotherapy | No | 66 |
Yes | 34 | |
Chemotherapy | No | 69 |
Yes | 31 | |
Beta value | WHO histological types A–B3 (median/range) | WHO histological type C (median/range) |
cg05784862 KSR1 | 61.5 (19–70) | 42 (0–49) |
cg07154254 ELF3 | 30 (8–40) | 16 (0–20) |
cg02543462 IL1RN | 67 (13–80) | 24.5 (0–40) |
cg06288355 RAG1 | 40 (27–88) | 77.5 (60–92) |